Bruce Cohen has spent more than 25 years in leadership positions in life science and high tech companies. He was the founding President and CEO of three biotechnology companies: VitaPath Genetics, Cellerant Therapeutics and Acacia Biosciences. He also serves as CFO for GeneSoft Pharmaceuticals. In addition he held senior positions in business development and marketing at SEQUUS and Baxter. He has an MBA from Harvard Business School.

Todd Lorenz has been working with biotech start-ups for almost 20 years on funding, diligence and the proactive coordination of their IP strategy with ongoing research, regulatory and transactional developments. He co-founded Myocept with Lars Peters in 2008 and continues to maintain his active legal practice at Arnold & Porter. He received his scientific training at RPI and Harvard Medical School and his legal training at Boston University.

Lars Peters has worked in research and product development in the biotech industry for more than 20 years with a particular emphasis on protein engineering and recombinant protein expression. He previously served as a Director of R&D at Qiagen and VP of R&D at Eppendorf 5Prime Inc. in Colorado, Before that, he co-founded biotech start-up InVitek GmbH in Germany. Lars received his graduate degree from the Lomonossov Moscow State University.